Alan Patrick Baltz, MD

Full Member

Research Program:

Cancer Therapeutics

Faculty Rank:

Assistant Professor

Campus:

University of Arkansas for Medical Sciences

College:

College of Medicine

Department:

Hematology/Oncology

Cancer Research Interest

Disease Site Focus: Leukemia/ Lymphoma
Research Focus Area: Treatment, Diagnosis/ Prognosis, Carcinogenesis
Type of Research: Clinical, Translational
Research Keywords: B-cell lymphoma, CAR-T, cellular therapy, BiTE Therapy, Cancer Immunotherapy, Classical Hematology, Gene Therapy, Personalized Cancer Care, Cancer Supportive Care
Research Interest Statement: As a new faculty member and UAMS fellow, my existing research projects and publications have focused on delivery of guideline-directed cancer care, cancer supportive care and survivorship, as well as novel cellular therapies and their toxicities. My current research interests include CAR-T and cellular therapies for Hematologic malignancies. I am currently enrolling patients and preparing to participate as a site PI for clinical trials utilizing these therapies primarily for B-cell lymphomas and other lymphoid malignancies. I also have an interest in novel immunotherapies, targeted treatments, and gene-therapies that are being studied and introduced for various benign “Classical Hematologic Disorders” including hemophilia, thalassemia, and sickle cell disease. It is my fervent hope and vocation to make innovative new treatment strategies available and accessible to our complex and often under-served Arkansan patients with various hematologic conditions.

Fugere T, Baltz A, Mukherjee A, [et al.]. Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity. Cancers. 2023 15(21). PMID: 37958323. PMCID: PMC10647774.
Baltz AP, Siegel ER, Kamal AH, [et al.]. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data. JCO oncology practice. 2022:OP2200500. PMID: 36375114. PMCID: PMC9970287.